Introduction
MSC transformation
Spontaneous mouse MSC transformation
Transformation after | Type of sarcoma | Associated genetic event(s) | Reference |
---|---|---|---|
Long term culture | Osteosarcoma | Aneuploidy + CDKN2A/p16 loss | [4] |
Abnormal karyotype | [6] | ||
Fibrosarcoma | p53 mutations | [24] | |
Chromosomal instability + TERT and c-myc expression | [16] | ||
Undiff. soft tissue sarcomas | Aneuploidy + chromosomal translocations | [17] | |
Short term culture | Soft tissue sarcomas | Aneuploidy | [18] |
Induced mouse MSC transformation
Sarcomas without specific chromosomal translocation | ||||
---|---|---|---|---|
Cell type | Inactivated gene(s) | Expressed gene(s)/treatment | Type of sarcoma | Reference |
mASCs | p21 + p53 | - | “Fibrosarcoma” | [20] |
p53 or p53 + Rb | - | Leiomyosarcoma | [7] | |
BM-mMSCs | INK4A/ARF | c-myc | Osteosarcoma | [24] |
Osteoblastic lineage | p53 or p53 + Rb | - | Osteosarcoma | |
Mesenchymal cells of limb buds | p53 | - | Osteosarcoma | [23] |
p53 + Rb | - | Undifferentiated sarcoma | [23] | |
Muscle, uterus | p53 orINK4A/ARF | K-RAS | High-grade sarcoma with myofibroblastic differentiation | [25] |
Muscle | p53 | K-RAS | Pleomorphic rhabdomyosarcoma | [18] |
Smooth muscle lineage | PTEN | - | Leiomyosarcoma | [17] |
MSC progenitors | APC | - | Aggressive fibromatosis | [67] |
Sarcomas with specific chromosomal translocation
| ||||
Cell type
|
Expressed fusion gene
|
Type of sarcoma
|
Reference
| |
BM-mMSCs | EWS-FLI-1 | Ewing sarcoma | [63] | |
EWS-FLI-1 | Ewing sarcoma | [65] | ||
FUS-CHOP | Myxoid liposarcoma | [11] | ||
PAX3/7-FKHR | Alveolar rhabdomyosarcoma | [71] | ||
mASCs | FUS- CHOP | Liposarcoma | [11] | |
Mesenchymal cells of limb buds | EWS-FLI-1 | Ewing sarcoma | [65] | |
Differentiated muscle cells (MYF6-expressing cells) | PAX3-FKHR | Liposarcoma | [70] |
Human MSC transformation
Type of sarcomas | Expressed gene(s)/treatment | Reference |
---|---|---|
Undifferentiated spindle cell sarcoma | hTERT + HPV16 E6/E7 + SV40-ST + H-RAS | [44] |
hTERT + SV40-LT + H-RAS | [13] | |
hTERT + H-RAS + BMI-1 | [43] | |
Tumors with smooth muscle and bone properties | hTERT4 | [33] |
Undifferentiated pleomorphic sarcomas | DKK1 + SV40-LT | [14] |
MSCs as the origin of sarcomas and tumour type specificity
Sarcoma type | Cell of origin | Targeted genes | Reference |
---|---|---|---|
Osteosarcoma | Mouse BMMSCs | - | [4] |
- | [6] | ||
C-myc overexpression and Ink4a/Arf knockout | [16] | ||
Mouse osteoblast precursors | Tp53, Rb double knockout | [56] | |
Mouse osteoblasts | Tp53 knockout | [57] | |
Tp53 knockout | [17] | ||
Leiomyosarcomas | Mouse AMSCs | Tp53 knockout | [14] |
Tp53 knockout | [24] | ||
Mouse smooth muscle lineage cells | Pten knockout | [30] | |
“Fibrosarcoma” | Mouse BMMSCs | - | [58] |
Aged mouse BMMSCs | - | [25] | |
Mouse AMSCs | P21 knockout, Tp53 heterozygous knockout | [24] | |
Pleomorphic rhabdomyosarcoma | Mouse skeletal muscle cells | K-ras overexpression and Tp53 knockout | [32] |